Courses | Page 10 | AUA University

Topic

Core Curriculum Related Education

Title	Category	Credit	Event Date	Price
New AUA Guideline (2024): Salvage Therapy for Prostate Cancer Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The course details the 2024 AUA Guidelines for salvage therapy following initial treatment of localized prostate cancer, focusing on integral aspects of salvage treatments, risk stratification and advanced imaging. Participants will gain insights into the timing and appropriate use of salvage radiation therapy with or without androgen deprivation therapy (ADT), the use of risk stratification tools and the application of next-generation imaging in patients with biochemical recurrence.
Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This course will focus on specific topics discussed in the recent AUA Practice Guidelines for non-muscle invasive bladder cancer (NMIBC) and detail strategies to manage common clinical predicaments involved in the management of these tumors. The course will include short didactic lectures by each of the faculty but will focus predominantly on case presentations highlighting common and often perplexing topics in NMIBC.
Life Long Learning Prep Course Webcast: Module 1: Oncology, Urinary Diversion and Adrenal (2021)				$1,055.00	Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	This new AUAUniversity podcast episode will address mechanisms behind infectious complications as well as the health care consequences of infections following prostate biopsy. Faculty will present real world and trial data pertaining to rates and associated factors for infections and provide practical measures to reduce these complications, including transperineal and transrectal approach (standard enema; antibiotic enema; iodine/other rectal prep; needle disinfection).
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Webcast (2023)		1.50 AMA PRA Category 1 Credit™ 1.50 Non-Physician Participation		$0.00	Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice (2023) is an exciting new educational initiative to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course features a Moderator and three other subject matter experts engaging in an interactive, interview-style presentation and discussion.
Incorporating Genomic Testing and Advanced Imaging For Prostate Cancer Into Your Practice Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	There are multiple genomic tests and advanced imaging modalities (MRI, prostate-specific membrane antigen PET, etc.) currently available for men to detect and risk-stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc.) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc.). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling and cascade testing of family members.
How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local...		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The learners will understand the following critical clinical aspects with regard to the clinical application of prostate-specific membrane antigen (PSMA) PET/CT; scanning mode of action of PSMA PET/CT; pitfalls of PSMA PET/CT; diagnostic accuracy depending on PSA, PSA double time, prostate cancer histology; application of PSMA PET/CT to identify patients with intrapelvic nodal relapse who will benefit from local therapy such as salvage lymphadenectomy or stereotactic radiation therapy; application of PSMA PET/CT to identify patients with organ-confined radiorecurrent local relapse of prosta
Global Advancements in Bladder Cancer Webcast (2023)		1.50 AMA PRA Category 1 Credit™ 1.50 Non-Physician Participation		$0.00
Germline Testing in GU Cancers – How I Do It Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:Germline Testing in GU Cancers – How I Do It (2023)
Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:
Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This case-based interactive course describes the role of germline genetics in urological cancers and how the identification of an alteration may impact precision oncology. We will provide a concise and comprehensive review of hereditary cancer genetics, discuss genetic risk assessment, diagnosis and treatment for a range of hereditary kidney, adrenal, upper tract and prostate cancer syndromes. We will review current National Comprehensive Cancer Network and AUA Guidelines for genetic evaluation of patients with kidney, adrenal, upper tract and prostate cancers.
Early Detection of Prostate Cancer: AUA/SUO Guideline Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)
Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA is offering phase two of an educational series to update urologists and advanced practice providers (APPs) on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. Part II will consist of two live webinars, one designed specifically for urologists and the other for APPs. The live virtual courses will feature a multidisciplinary panel engaging in a lively discussion on this topic.
Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This is a repeat course from prior years, with review of advanced and metastatic prostate, bladder and kidney cancer. Most recent treatment guidelines are reviewed along with the studies that support them. Different disease spaces in oncologic care are discussed, including the medications used to treat them, their mechanism, side effects and efficacy. Role of the advanced practice provider is discussed for each tumor type. Finally, cases are presented along with management options for audience participation.
AUA Advanced Prostate Cancer Guidelines Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This course will be comprehensive AUA Guidelines on advanced prostate cancer in the management and outcomes of men with advanced, metastatic and castrate-resistant prostate cancer (CRPC). The course will include risk stratification, germline testing, PET imaging, the use of androgen deprivation therapy in combination with novel androgen axis therapy and chemotherapy in men with newly diagnosed metastatic hormone-sensitive prostate cancer. Early treatment intensification and evidenced-based guidelines will be covered.

Pages